Literature DB >> 25252954

A novel mouse model for the hyper-IgM syndrome: a spontaneous activation-induced cytidine deaminase mutation leading to complete loss of Ig class switching and reduced somatic hypermutation.

Carin I M Dahlberg1, Minghui He2, Torkild Visnes3, Magda Liz Torres1, Elena M Cortizas4, Ramiro E Verdun4, Lisa S Westerberg5, Eva Severinson6, Lena Ström3.   

Abstract

We describe a spontaneously derived mouse line that completely failed to induce Ig class switching in vitro and in vivo. The mice inherited abolished IgG serum titers in a recessive manner caused by a spontaneous G → A transition mutation in codon 112 of the aicda gene, leading to an arginine to histidine replacement (AID(R112H)). Ig class switching was completely reconstituted by expressing wild-type AID. Mice homozygous for AID(R112H) had peripheral B cell hyperplasia and large germinal centers in the absence of Ag challenge. Immunization with SRBCs elicited an Ag-specific IgG1 response in wild-type mice, whereas AID(R112H) mice failed to produce IgG1 and had reduced somatic hypermutation. The phenotype recapitulates the human hyper-IgM (HIGM) syndrome that is caused by point mutations in the orthologous gene in humans, and the AID(R112H) mutation is frequently found in HIGM patients. The AID(R112H) mouse model for HIGM provides a powerful and more precise tool than conventional knockout strategies.
Copyright © 2014 by The American Association of Immunologists, Inc.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25252954      PMCID: PMC4201989          DOI: 10.4049/jimmunol.1401242

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  24 in total

1.  Binding of Ikaros to germline Ig heavy chain gamma1 and epsilon promoters.

Authors:  Lena Ström; Mats Lundgren; Eva Severinson
Journal:  Mol Immunol       Date:  2003-03       Impact factor: 4.407

2.  Efficient IgG-mediated suppression of primary antibody responses in Fcgamma receptor-deficient mice.

Authors:  M C Karlsson; S Wernersson; T Diaz de Ståhl; S Gustavsson; B Heyman
Journal:  Proc Natl Acad Sci U S A       Date:  1999-03-02       Impact factor: 11.205

3.  Molecular characterization of single memory B cells.

Authors:  M G McHeyzer-Williams; G J Nossal; P A Lalor
Journal:  Nature       Date:  1991-04-11       Impact factor: 49.962

4.  Heavy chain variable region contribution to the NPb family of antibodies: somatic mutation evident in a gamma 2a variable region.

Authors:  A L Bothwell; M Paskind; M Reth; T Imanishi-Kari; K Rajewsky; D Baltimore
Journal:  Cell       Date:  1981-06       Impact factor: 41.582

5.  Characterization of CD40-dependent immunoglobulin class switching.

Authors:  L Ström; J Laurencikiené; A Miskiniené; E Severinson
Journal:  Scand J Immunol       Date:  1999-05       Impact factor: 3.487

6.  Class switch recombination and hypermutation require activation-induced cytidine deaminase (AID), a potential RNA editing enzyme.

Authors:  M Muramatsu; K Kinoshita; S Fagarasan; S Yamada; Y Shinkai; T Honjo
Journal:  Cell       Date:  2000-09-01       Impact factor: 41.582

7.  Specific expression of activation-induced cytidine deaminase (AID), a novel member of the RNA-editing deaminase family in germinal center B cells.

Authors:  M Muramatsu; V S Sankaranand; S Anant; M Sugai; K Kinoshita; N O Davidson; T Honjo
Journal:  J Biol Chem       Date:  1999-06-25       Impact factor: 5.157

8.  AID mutant analyses indicate requirement for class-switch-specific cofactors.

Authors:  Van-Thanh Ta; Hitoshi Nagaoka; Nadia Catalan; Anne Durandy; Alain Fischer; Kohsuke Imai; Shigeaki Nonoyama; Junko Tashiro; Masaya Ikegawa; Satomi Ito; Kazuo Kinoshita; Masamichi Muramatsu; Tasuku Honjo
Journal:  Nat Immunol       Date:  2003-08-10       Impact factor: 25.606

Review 9.  Pathophysiology of B-cell intrinsic immunoglobulin class switch recombination deficiencies.

Authors:  Anne Durandy; Nadine Taubenheim; Sophie Peron; Alain Fischer
Journal:  Adv Immunol       Date:  2007       Impact factor: 3.543

10.  Alternative end-joining and classical nonhomologous end-joining pathways repair different types of double-strand breaks during class-switch recombination.

Authors:  Elena M Cortizas; Astrid Zahn; Maurice E Hajjar; Anne-Marie Patenaude; Javier M Di Noia; Ramiro E Verdun
Journal:  J Immunol       Date:  2013-10-21       Impact factor: 5.422

View more
  5 in total

1.  Abrogated AID Function Prolongs Survival and Diminishes Renal Pathology in the BXSB Mouse Model of Systemic Lupus Erythematosus.

Authors:  Jing Zhu; Alayna N Hay; Ashley A Potter; Madison W Richwine; Thomas Sproule; Tanya LeRoith; John Wilson; Muneer G Hasham; Derry C Roopenian; Caroline M Leeth
Journal:  J Immunol       Date:  2020-01-27       Impact factor: 5.422

2.  Genetic and Small Molecule Disruption of the AID/RAD51 Axis Similarly Protects Nonobese Diabetic Mice from Type 1 Diabetes through Expansion of Regulatory B Lymphocytes.

Authors:  Jeremy J Ratiu; Jeremy J Racine; Muneer G Hasham; Qiming Wang; Jane A Branca; Harold D Chapman; Jing Zhu; Nina Donghia; Vivek Philip; William H Schott; Clive Wasserfall; Mark A Atkinson; Kevin D Mills; Caroline M Leeth; David V Serreze
Journal:  J Immunol       Date:  2017-05-01       Impact factor: 5.422

3.  The Small Rho GTPases Rac1 and Rac2 Are Important for T-Cell Independent Antigen Responses and for Suppressing Switching to IgG2b in Mice.

Authors:  Natalija Gerasimčik; Minghui He; Carin I M Dahlberg; Nikolai V Kuznetsov; Eva Severinson; Lisa S Westerberg
Journal:  Front Immunol       Date:  2017-10-06       Impact factor: 7.561

4.  Activation-induced cytidine deaminase overexpression in double-hit lymphoma: potential target for novel anticancer therapy.

Authors:  Jingcheng Zhang; Yifen Shi; Mingzhe Zhao; Huixian Hu; He Huang
Journal:  Sci Rep       Date:  2020-08-25       Impact factor: 4.379

Review 5.  Higher Incidence of B Cell Malignancies in Primary Immunodeficiencies: A Combination of Intrinsic Genomic Instability and Exocytosis Defects at the Immunological Synapse.

Authors:  Jérôme Mastio; Mezida B Saeed; Hannah Wurzer; Max Krecke; Lisa S Westerberg; Clément Thomas
Journal:  Front Immunol       Date:  2020-11-09       Impact factor: 7.561

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.